| Sacred Heart Rehabilitation Center, Inc | |
|
400 Medical Park Dr Watervliet MI 49098-9225 | |
| (810) 392-2167 | |
| Not Available |
| Full Name | Sacred Heart Rehabilitation Center, Inc |
|---|---|
| Speciality | Community/behavioral Health |
| Location | 400 Medical Park Dr, Watervliet, Michigan |
| Authorized Official Name and Position | Paula Nelson (PRESIDENT/CEO) |
| Authorized Official Contact | 8103922167 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Sacred Heart Rehabilitation Center, Inc 400 Stoddard Rd Richmond MI 48062-2505 Ph: () - | Sacred Heart Rehabilitation Center, Inc 400 Medical Park Dr Watervliet MI 49098-9225 Ph: (810) 392-2167 |
| NPI Number | 1649706045 |
|---|---|
| Provider Enumeration Date | 05/04/2017 |
| Last Update Date | 05/04/2017 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649706045 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 251S00000X | Community/behavioral Health | 0110113 (Michigan) | Primary |
News Archive
Since 1980, the incidence of ductal carcinoma in situ, or DCIS, one of the most common kinds of early stage breast cancer, has increased more than sevenfold. This sharp increase in DCIS – which is a tumor that contains cancer-like cells but is not considered "true" cancer because the cells have not invaded normal breast tissue – has been accompanied by a flattening in the incidence of true invasive breast cancer.
A temporary suspension of the initial dose of hepatitis B vaccine appears to have contributed to fewer newborns being vaccinated for hepatitis B in 2000 than in 1998, according to a study published in the May 19 issue of the Journal of the American Medical Association (JAMA).
A new study published this week online in Emerging Infectious Diseases suggests that transmission of a protozoan parasite from insects may also cause leishmaniasis-like symptoms in people
A team of researchers, led by Dr Clare Fedele and Professor Christina Mitchell at Monash University, Australia, has made a significant discovery in breast cancer research that identifies a particular protein's role in tumor growth. They have also devised a new antibody that can identify the protein and measure its presence in breast cancer tissue.
› Verified 5 days ago